OBJECTIVE: To assess the relation between ST segment elevation during the dobutamine stress test and late improvement of function after acute Q wave myocardial infarction. PATIENTS AND DESIGN: 70 patients were studied a mean (SD) 8 (3) days after acute myocardial infarction with high dose dobutamine-atropine stress echocardiography and a follow up echocardiogram at 85 (10) days. A score model based on 16 segments and four grades was used to assess left ventricular function. Functional improvement was defined as a reduction of wall motion score > or = 1 in > or = 1 segments at follow up. INTERVENTION: Myocardial revascularisation was performed in 23 patients (33%) before follow up studies. RESULTS: ST segment elevation occurred in 40 patients (57%). Late functional improvement occurred in 35 patients (50%). Functional improvement was more common in patients with ST segment elevation (68% v 30%, P < 0.005) and they had a higher mean (SD) number of improved segments at follow up (1.9 (2.2) v 0.5 (1.1), P < 0.005). The wall motion score index decreased between baseline and follow up in patients with ST segment elevation (1.54 (0.50) v 1.48 (0.43), P < 0.05) but not in patients without ST segment elevation (1.39 (0.60) v 1.45 (0.47)). The accuracy of ST segment elevation for the prediction of functional improvement was similar to that of low dose dobutamine echocardiography in patients with anterior infarction (80% v 83%) and in patients who underwent revascularisation (78% v 83% respectively). CONCLUSION: In patients with a recent Q wave myocardial infarction, dobutamine-induced ST segment elevation is a valuable marker of myocardial viability particularly when the test is performed without or with suboptimal echocardiographic imaging.
OBJECTIVE: To assess the relation between ST segment elevation during the dobutamine stress test and late improvement of function after acute Q wave myocardial infarction. PATIENTS AND DESIGN: 70 patients were studied a mean (SD) 8 (3) days after acute myocardial infarction with high dose dobutamine-atropine stress echocardiography and a follow up echocardiogram at 85 (10) days. A score model based on 16 segments and four grades was used to assess left ventricular function. Functional improvement was defined as a reduction of wall motion score > or = 1 in > or = 1 segments at follow up. INTERVENTION: Myocardial revascularisation was performed in 23 patients (33%) before follow up studies. RESULTS: ST segment elevation occurred in 40 patients (57%). Late functional improvement occurred in 35 patients (50%). Functional improvement was more common in patients with ST segment elevation (68% v 30%, P < 0.005) and they had a higher mean (SD) number of improved segments at follow up (1.9 (2.2) v 0.5 (1.1), P < 0.005). The wall motion score index decreased between baseline and follow up in patients with ST segment elevation (1.54 (0.50) v 1.48 (0.43), P < 0.05) but not in patients without ST segment elevation (1.39 (0.60) v 1.45 (0.47)). The accuracy of ST segment elevation for the prediction of functional improvement was similar to that of low dose dobutamine echocardiography in patients with anterior infarction (80% v 83%) and in patients who underwent revascularisation (78% v 83% respectively). CONCLUSION: In patients with a recent Q wave myocardial infarction, dobutamine-induced ST segment elevation is a valuable marker of myocardial viability particularly when the test is performed without or with suboptimal echocardiographic imaging.
Authors: A Margonato; C Ballarotto; F Bonetti; A Cappelletti; M Sciammarella; D Cianflone; S L Chierchia Journal: J Am Coll Cardiol Date: 1992-04 Impact factor: 24.094
Authors: M Arnese; J H Cornel; A Salustri; A Maat; A Elhendy; A E Reijs; F J Ten Cate; D Keane; A H Balk; J R Roelandt Journal: Circulation Date: 1995-06-01 Impact factor: 29.690
Authors: A Salustri; P Garyfallidis; A Elhendy; M Ciavatti; J H Cornel; A Gemelli; F J Ten Cate; J R Roelandt; P M Fioretti Journal: Am J Cardiol Date: 1995-03-01 Impact factor: 2.778
Authors: A Elhendy; M L Geleijnse; J R Roelandt; R T van Domburg; J H Cornel; F J TenCate; J Postma-Tjoa; A E Reijs; G M el-Said; P M Fioretti Journal: Am J Cardiol Date: 1995-09-01 Impact factor: 2.778
Authors: S C Smart; S Sawada; T Ryan; D Segar; L Atherton; K Berkovitz; P D Bourdillon; H Feigenbaum Journal: Circulation Date: 1993-08 Impact factor: 29.690
Authors: M Galli; C Marcassa; R Bolli; P Giannuzzi; P L Temporelli; A Imparato; P L Silva Orrego; R Giubbini; A Giordano; L Tavazzi Journal: Circulation Date: 1994-09 Impact factor: 29.690
Authors: A Margonato; S L Chierchia; R G Xuereb; M Xuereb; G Fragasso; A Cappelletti; C Landoni; G Lucignani; F Fazio Journal: J Am Coll Cardiol Date: 1995-04 Impact factor: 24.094
Authors: A Salustri; A Elhendy; P Garyfallydis; M Ciavatti; J H Cornel; F J ten Cate; E Boersma; A Gemelli; J R Roelandt; P M Fioretti Journal: Am J Cardiol Date: 1994-11-01 Impact factor: 2.778